Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 33(9): 2393-407, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2391684

ABSTRACT

A series of diarylsulfonylureas with exceptionally broad-spectrum activity against syngeneic rodent solid tumors in vivo is described. Their discovery resulted from a program dedicated to in vivo screening for novel oncolytics in solid tumor models, rather than traditional ascites leukemia models. The structures, oral efficacy, side-effect profile, and mechanism of action of these sulfonylureas appear to be distinct from previously known classes of oncolytics. An extensive series of analogues was prepared to probe structure-activity relationships (SAR), with particular focus on the substituent patterns of each aryl domain. Quantitative analysis of these substituent SARs, using the method of cluster significance analysis, showed the lipophilicity of the substituents to be the dominant determinant of activity. One compound from the series, LY186641 (104, sulofenur), has progressed to Phase I clinical trials as an antitumor drug.


Subject(s)
Antineoplastic Agents/chemical synthesis , Sulfonylurea Compounds/chemical synthesis , Adenocarcinoma/drug therapy , Animals , Antineoplastic Agents/therapeutic use , Chemical Phenomena , Chemistry , Humans , Lymphoma, Non-Hodgkin/drug therapy , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Inbred DBA , Multiple Myeloma/drug therapy , Rats , Rats, Inbred Strains , Structure-Activity Relationship , Sulfonylurea Compounds/therapeutic use , Tumor Cells, Cultured/drug effects
2.
J Antibiot (Tokyo) ; 42(8): 1253-67, 1989 Aug.
Article in English | MEDLINE | ID: mdl-2668243

ABSTRACT

A series of 20-deoxo-20-cyclic (alkylamino) derivatives of tylosin, desmycosin, macrocin and lactenocin was prepared by reductive amination of the C-20 aldehyde group. The majority of the compounds were prepared using metal hydrides (sodium cyanoborohydride or sodium borohydride) as the reducing agents and a suitable cyclic alkylamine. Subsequently, a more convenient procedure was developed using formic acid as a reducing agent. The C-20 amino derivatives prepared from desmycosin exhibited good in vitro antimicrobial activity against Pasteurella haemolytica and Pasteurella multocida (MIC range of 0.78 approximately 6.25 micrograms/ml) as well as Mycoplasma species (MIC range of 0.39 approximately 6.25 micrograms/ml). Several derivatives showed excellent oral efficacy against infections caused by P. multocida in chicks. One of these derivatives, 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin (tilmicosin or EL-870) was selected for development as a therapeutic agent for pasteurellosis in calves and pigs.


Subject(s)
Anti-Bacterial Agents , Leucomycins/chemical synthesis , Macrolides , Tylosin/analogs & derivatives , Amination , Animals , Chickens , Leucomycins/pharmacology , Leucomycins/therapeutic use , Mice , Microbial Sensitivity Tests , Molecular Structure , Mycoplasma/drug effects , Oxidation-Reduction , Pasteurella/drug effects , Pasteurella Infections/drug therapy , Streptococcal Infections/drug therapy , Streptococcus pyogenes
SELECTION OF CITATIONS
SEARCH DETAIL
...